Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NTLA
Recent news which mentions NTLA
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Intellia's Gene-Editing Candidate Shows Durability In ATTR Amyloidosis
June 24, 2022
Tickers
NTLA
REGN
Tags
REGN
General
NTLA
From
Benzinga
BMO Initiates Coverage On This Gene Editing Spearhead
June 17, 2022
Tickers
EDIT
NTLA
Tags
NTLA
Initiation
Market News
From
Benzinga
Analyst Ratings for Intellia Therapeutics
June 16, 2022
Tickers
NTLA
Tags
BZI/AAR
Market News
NTLA
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2022
June 16, 2022
Tickers
AIRS
AJG
APLE
AWI
Tags
Analyst Ratings
Market News
U
From
Benzinga
Analyst Ratings for Intellia Therapeutics
May 24, 2022
Tickers
NTLA
Tags
Benzinga
BZI/AAR
NTLA
From
Benzinga
Why Editas Medicine's Shares Fell 28.9% This Week
May 13, 2022
Tickers
CRSP
EDIT
NTLA
Tags
^IXIC
Recent Press Releases
NTLA
From
Motley Fool
10 Biggest Price Target Changes For Monday
May 09, 2022
Tickers
CI
EPAM
GH
K
Tags
Small Cap
SPCE
NTLA
From
Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Tickers
ABUS
AGIO
ALDX
ARGX
Tags
GLPG
NVS
IBB
From
Benzinga
Earnings Preview For Intellia Therapeutics
May 04, 2022
Tickers
NTLA
Tags
BZI/EP
Earnings
Benzinga
From
Benzinga
How To Attend Intellia Therapeutics Q1 2022 Earnings Conference Call
May 02, 2022
Tickers
NTLA
Tags
Market News
NTLA
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022
April 28, 2022
Tickers
ACHR
ALL
AM
ARVN
Tags
KO
Intraday Update
Analyst Ratings
From
Benzinga
4 Analysts Have This to Say About Intellia Therapeutics
April 28, 2022
Tickers
NTLA
Tags
Benzinga
BZI/AAR
Analyst Ratings
From
Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 21, 2022
Tickers
HLBZ
HNST
HYFM
HYRE
Tags
MRTX
IDN
NRXP
From
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
Tickers
ACLX
ADVM
AFCG
ALLK
Tags
VLON
BMEA
KOPN
From
Benzinga
3 Top Biotech Stocks Ready for a Bull Run
April 20, 2022
Tickers
BNTX
NTLA
PFE
REGN
Tags
SNY
BAYR/Y
BNTX
From
Motley Fool
3 Ominous Reasons to Avoid This Biotech Pioneer
April 19, 2022
Tickers
CRSP
EDIT
NTLA
Tags
Market News
NTLA
Recent Press Releases
From
Motley Fool
CRISPR Stocks Are Huge -- Here's Why They'll Get Even Bigger by 2030
April 13, 2022
Tickers
CRSP
EDIT
NTLA
VRTX
Tags
VRTX
EDIT
CRSP
From
Motley Fool
Who Benefits From Amazon's Stock Split?
March 16, 2022
Tickers
AAPL
AMZN
BMBL
CMG
Tags
JSDA
GS
BMBL
From
Motley Fool
FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
March 15, 2022
Tickers
BLUE
NTLA
Tags
News
BLUE
Penny Stocks
From
Benzinga
Here's How Much $100 Invested In Intellia Therapeutics 5 Years Ago Would Be Worth Today
March 15, 2022
Tickers
NTLA
Tags
Market News
NTLA
Benzinga
From
Benzinga
Intellia's CRISPR-Engineered Cell Therapy Receives FDA Orphan Drug Tag For Bone Marrow Cancer
March 10, 2022
Tickers
NTLA
Tags
Market News
NTLA
FDA
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2022
March 07, 2022
Tickers
AAL
AU
AUGX
AZUL
Tags
LYG
UGI
AAL
From
Benzinga
63 Biggest Movers From Yesterday
March 04, 2022
Tickers
AEO
ANGH
APCX
ATNX
Tags
NCNA
SUP
Benzinga
From
Benzinga
Is Intellia a Good Gene-Editing Stock to Buy Now?
March 03, 2022
Tickers
NTLA
REGN
Tags
REGN
Recent Press Releases
Market News
From
Motley Fool
Can Biotech Stocks Provide Crypto-Like Growth for Your Portfolio?
March 03, 2022
Tickers
BNTX
BTC
CRSP
ETH
Tags
ETH
MRNA
Recent Press Releases
From
Motley Fool
80 Biggest Movers From Yesterday
March 02, 2022
Tickers
ALBO
AMBA
AMLX
ANPC
Tags
HOWL
ENDP
News
From
Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
March 01, 2022
Tickers
AMBA
AREB
ATRA
ATXI
Tags
AMBA
Benzinga
QSI
From
Benzinga
Analyst Ratings For Intellia Therapeutics
March 01, 2022
Tickers
NTLA
Tags
Benzinga
Market News
NTLA
From
Benzinga
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
March 01, 2022
Tickers
ABBV
AMRN
AMRS
AVID
Tags
EDIT
CTIC
Penny Stocks
From
Benzinga
Intellia Shares Updated Data On Gene Editing Durability In Rare Disease
March 01, 2022
Tickers
NTLA
REGN
Tags
Trading Ideas
News
Briefs
From
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
